Hu Wenbing, Gao Wenyu, Liu Zongmin, Fang Zhifeng, Zhao Jianxin, Zhang Hao, Lu Wenwei, Chen Wei
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Microorganisms. 2022 Jan 26;10(2):297. doi: 10.3390/microorganisms10020297.
is prevalent in the human gut and is a potential candidate for next-generation probiotics (NGPs) or biotherapeutics. However, the biodiversity and physiological characteristics of remain unclear. This study isolated 26 novel strains from human feces using a combination of negative screening and prime-specific PCR amplification (NSPA). Based on a 16S rRNA gene analysis, strains can be classified into two main phylogroups (phylogroups I and II), which were further clustered into five subgroups (I-A, II-B, II-C, II-D, and II-E). The ultrastructure, colony morphology, growth performance, and short-chain fatty acids (SCFAs)-producing ability were found to be variable among these isolates. The optimal pH for the isolates growth ranged between 6.0 and 7.0, while most isolates were inhibited by 0.1% of bile salts. Antimicrobial resistance profiles showed that all isolates were susceptible to vancomycin, whereas >80% were kanamycin and gentamicin resistant. Additionally, all strains can utilize maltose, cellulose, and fructose but not xylose, sorbose, and 2'-FL. Overall, our work provides new insights into the biodiversity and physiological characteristics of , as well as the choices of strains suitable for NGPs.
在人类肠道中普遍存在,是下一代益生菌(NGPs)或生物治疗剂的潜在候选者。然而,其生物多样性和生理特征仍不清楚。本研究使用阴性筛选和引物特异性PCR扩增(NSPA)相结合的方法,从人类粪便中分离出26株新型菌株。基于16S rRNA基因分析,这些菌株可分为两个主要系统发育组(系统发育组I和II),进一步聚类为五个亚组(I-A、II-B、II-C、II-D和II-E)。发现这些分离株的超微结构、菌落形态、生长性能和产生短链脂肪酸(SCFAs)的能力存在差异。分离株生长的最适pH值在6.0至7.0之间,而大多数分离株受到0.1%胆盐的抑制。抗菌药物耐药性谱显示,所有分离株对万古霉素敏感,而>80%对卡那霉素和庆大霉素耐药。此外,所有菌株都能利用麦芽糖、纤维素和果糖,但不能利用木糖、山梨糖和2'-FL。总体而言,我们的工作为该菌的生物多样性和生理特征以及适合NGPs的菌株选择提供了新的见解。